GlobeImmune (GBIM) - NASDAQ
Company Description
GlobeImmune, Inc. is a biopharmaceutical company, which focuses on developing therapeutic products for cancer and infectious diseases based on its proprietary Tarmogen platform. The company has four product candidates in five ongoing clinical trials. It's cancer product candidate, GI-4000, is... More
Sector: Healthcare
Industry: Biotechnology
Country: United States